Navigation Links
Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
Date:1/24/2013

from similarly titled measures used by other companies.  Therefore, our non-GAAP financial measures may not be comparable to those used by other companies.  We have described the reconciliations of each of our non-GAAP financial measures described above to the most directly comparable GAAP financial measures.

We use these non-GAAP financial measures, and in particular non-GAAP operating loss, for internal managerial purposes and incentive compensation for senior management because we believe such measures are one important indicator of the strength and the operating performance of our business.  Analysts and investors frequently ask us for this information.  We believe that they use these measures to evaluate the overall operating performance of companies in our industry, including as a means of comparing period-to-period results and as a means of evaluating our results with those of other companies.

Our non-GAAP operating loss during the three months ended December 31, 2012 and 2011 was approximately $135,000 and $570,000, respectively.  Our non-GAAP operating loss during the nine months ended December 31, 2012 and 2011 was approximately $858,000 and $2.3 million, respectively.  The decrease in non-GAAP operating loss for the three months ended December 31, 2012 over the corresponding period a year ago is attributed to the increase in net sales and gross profit percent and the decrease in operating spending.  The decrease in non-GAAP operating loss for the nine months ended December 31, 2012 over the corresponding period a year ago is attributed to the increase in net sales and gross profit percent, which more than offset the increase in operating spending.

 Expense AdjustmentsThree-Months EndedGAAPShare-based  ExpenseDepreciationAmortization of IntangiblesNon-GAAPDecember 31, 2012Gross Profit

$4,856,000

$8,000

$8,000$4,872,000% of net sales

86.9%87.2%Operating Exp
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
2. Uroplasty To Participate In Two Upcoming Investor Conferences
3. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
4. Uroplasty To Participate In Two Upcoming Conferences
5. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
6. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
7. Uroplasty To Present At The JMP Securities Healthcare Conference
8. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
9. Uroplasty Announces Product Development and New Clinical Trial Initiatives
10. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  A promising University of Michigan research project focused ... and lethal subtype of leukemia has received a significant ... biotechnology company, Kura Oncology.  The Leukemia & Lymphoma Society ... Professor Jolanta Grembecka , Ph.D, in collaboration with ... Michigan, since 2009. Kura Oncology is ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ ... (NASDAQ: VSCI ) shareholders have voted at ... today to approve the previously announced agreement and ... "We are pleased with the outcome of ... thank both shareholder groups for approving the merger ...
(Date:3/30/2015)... Perrigo Company plc (NYSE: PRGO ; ... Products®," today announced that it has completed the acquisition ... cash and equity transaction valued at approximately €3.8 billion, ... Sellers are Marc Coucke , Waterland Private Equity ...   "The combination of Perrigo and Omega ...
Breaking Medicine Technology:Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5
... VEGAS, Aug. 5, 2011 Jury selection in the second ... has begun in Clark County, Nevada. The Nevada Supreme Court ... when it was determined by the court that nurse David ... Inc., "does not possess the requisite skill, knowledge or experience ...
... NxStage Medical, Inc. (Nasdaq: NXTM ... today announced that Jeffrey H. Burbank, Chief Executive ... participate in the following schedule of investor conferences. ... available at http://www.nxstage.com/ir.cfm at the time ...
Cached Medicine Technology:Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs 2NxStage Announces Third Quarter 2011 Investor Conference Schedule 2
(Date:3/30/2015)... March 30, 2015 Recently, 10 Best ... Water Awards, with the top three winners being Fiji water, ... the company’s website, along with other informative information about water. ... water, spring water, mineral water and sparkling water are among ... of the top exotic water brands highlighted on the ...
(Date:3/30/2015)... Pa. (PRWEB) March 30, 2015 ... the Halal certification for all current Epax® Ultra ... facility in Ålesund, Norway. The certification ensures the ... comply with the Islamic religious regulations for Halal. ... step in FMC’s efforts to further advance its ...
(Date:3/30/2015)... 2015 Slidezilla, an app from the ... app that innovates the fun and simplicity of photo ... animated photo slideshows and then instantly share them across ... "We wanted to create a slideshow app where users ... many fun options to personalize them. You can choose ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 V/NO (Virtually No ... a convenient flute for opening/closing and for reuse. Consumers simply ... the go. Health-conscious New Yorkers, professionals, and basically anyone can ... yet delicious to kick back socially or pair with meals ... “ V/NO is dealcoholized wine and that means Napa ...
(Date:3/30/2015)... California (PRWEB) March 30, 2015 ... as radioactive isotopes, radiopharmaceuticals are used as tracers ... global market for radiopharmaceuticals is driven by the ... in the field of cardiology, neurology, pulmonology, and ... by the well-established use of radioisotopes in diagnostic ...
Breaking Medicine News(10 mins):Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 2Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 3Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 4
... Oct. 25 Reaching out to a key,demographic, Sen. ... by Women,s Voices for Change, the New York-based group ... women,s health and well-being,in the menopause years. The interview ... ., "Right now, the uninsured are carrying a ...
... BOSTON October 25, 2007 Shire plc ... specialty biopharmaceutical company, today announced the results of ... Deficit Hyperactivity Disorder (ADHD) experienced significant improvements in ... with once-daily VYVANSE (lisdexamfetamine dimesylate), the first prodrug ...
... as HIV treatment improved and as HIV-related public health ... and seek care, that HIV-infected patients would seek care ... actually sicker when they begin therapy. The study is ... Diseases, currently available online. , The study, carried out ...
... Action allows Novavax to focus on its vaccine ... Oct. 25 Novavax, Inc.,(Nasdaq: NVAX ) ... Inc. to,terminate its manufacturing supply agreement for Estrasorb. ... Inc. (recently acquired by,Allergan, Inc.) in 2006 and ...
... The wildfires ravaging large,swathes of Southern California are ... billion, making them among the most expensive in ... Solutions (RMS),the world,s leading provider of products and ... to spread in this ongoing situation,losses are expected ...
... population is infected with Mycobacterium tuberculosis, the bacterium ... people died of the disease in 2005. Currently, ... regimen over a six- to nine-month period. This ... doses, which has given rise to drug-resistant strains ...
Cached Medicine News:Health News:VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment 2Health News:HIV patients sicker when seeking care than in the past 2Health News:Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb 2Health News:Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb 3Health News:California Wildfires Could Cost Insurers Over $1.5BN, Says RMS 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: